Mylan Approved to Market CF Treatments, TOBI Solution and TOBI Podhaler, in UK - Cystic Fibrosis News Today

Mylan Approved to Market CF Treatments, TOBI Solution and TOBI Podhaler, in UK  Cystic Fibrosis News Today

Mylan has been granted rights to market in the U.K. TOBI Solution and TOBI Podhaler to treat P. aeruginosa lung infections in cystic fibrosis patients.



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today